Contineum Therapeutics, Inc. Class A Common StockCTNMNASDAQ
Loading
Year-over-year net income growth rate
Latest
-18.48%
↓ 131% vs avg
Percentile
P25
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
59.89%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -18.48% |
| Q3 2025 | 20.25% |
| Q2 2025 | -0.31% |
| Q1 2025 | -9.78% |
| Q4 2024 | -41.86% |
| Q3 2024 | -13.96% |
| Q2 2024 | -7.03% |
| Q1 2024 | -8.34% |
| Q4 2023 | -24.28% |
| Q3 2023 | -115.04% |
| Q2 2023 | 961.61% |
| Q1 2023 | 35.78% |
| Q4 2022 | 0.00% |